Indiana health startups have raised $100M this year

Back to TopCommentsE-mailPrintBookmark and Share

After struggling recently to raise money, Hoosier health care and life sciences companies broke through in the first half of 2014, raising more than $100 million in venture capital.

Eighteen companies raised $100.8 million, more in six months than in any such stretch since Ohio-based BioEnterprise started keeping records on Midwest venture capital activity in 2005. And the pipeline of companies seeking investment is at record levels.

Investors seemed to rediscover the Midwest, pouring a record $777 million into 139 companies in the first half of 2014. The region tracked by BioEnterprise includes 10 states and western Pennsylvania. In the first half of 2013, Midwest companies raised $351 million.

“It’s been a banner first half for Midwest health care startups,” said Aram Nerpouni, CEO of the life sciences business development group. “Investment activity continued its upward trend and the company pipeline once again attracted broad investor interest with a record number of companies receiving funding."

The funding haul was big enough to catch the attention of the Wall Street Journal’s Venture Capital Dispatch publication.

Indiana posted the second-best performance among the 10 states when fundraising and deals are taken as a proportion of each state’s economy. The figures are derived from Bureau of Economic Analysis data for each state’s 2013 gross domestic product. On that basis, Hoosier life sciences companies raised $31.79 and created 5.7 deals for every $100,000 in gross state product.

Only Minnesota did better than Indiana's $100 million. With a slightly smaller economy, the Gopher State attracted $183.5 million on 43 deals.

Other states attracting hordes of cash were Ohio, with $155.3 million, and Michigan, with $113.9 million.

Each of the leading states’ totals was boosted by big deals. In Indiana, Warsaw-based Orthopediatrics Corp. raised a whopping $39 million from an existing investor, Connecticut-based Squadron Capital LLC, to help develop new products, expand its presence internationally and reduce its debt.

Because of the Orthopediatrics deal, more than half of Indiana's 2014 venture capital has gone to companies outside the Indianapolis area. Those companies include Fort Wayne-based BioPoly, Warsaw-based Solstice Medical and West Lafayette-based On Target Laboratories.

In the Indianapolis area, 10 companies raised a total of $39.5 million. The biggest chunk of that money, $16 million, went to Wellfount Corp., a health information technology company providing pharmaceuticals to long-term care institutions.

Other companies raising money included Indigo BioSystems, VoCare, Algaeon, SonarMed, hc1.com and AIT BioScience.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. How much you wanna bet, that 70% of the jobs created there (after construction) are minimum wage? And Harvey is correct, the vast majority of residents in this project will drive to their jobs, and to think otherwise, is like Harvey says, a pipe dream. Someone working at a restaurant or retail store will not be able to afford living there. What ever happened to people who wanted to build buildings, paying for it themselves? Not a fan of these tax deals.

  2. Uh, no GeorgeP. The project is supposed to bring on 1,000 jobs and those people along with the people that will be living in the new residential will be driving to their jobs. The walkable stuff is a pipe dream. Besides, walkable is defined as having all daily necessities within 1/2 mile. That's not the case here. Never will be.

  3. Brad is on to something there. The merger of the Formula E and IndyCar Series would give IndyCar access to International markets and Formula E access the Indianapolis 500, not to mention some other events in the USA. Maybe after 2016 but before the new Dallara is rolled out for 2018. This give IndyCar two more seasons to run the DW12 and Formula E to get charged up, pun intended. Then shock the racing world, pun intended, but making the 101st Indianapolis 500 a stellar, groundbreaking event: The first all-electric Indy 500, and use that platform to promote the future of the sport.

  4. No, HarveyF, the exact opposite. Greater density and closeness to retail and everyday necessities reduces traffic. When one has to drive miles for necessities, all those cars are on the roads for many miles. When reasonable density is built, low rise in this case, in the middle of a thriving retail area, one has to drive far less, actually reducing the number of cars on the road.

  5. The Indy Star announced today the appointment of a new Beverage Reporter! So instead of insightful reports on Indy pro sports and Indiana college teams, you now get to read stories about the 432nd new brewery open or some obscure Hoosier winery winning a county fair blue ribbon. Yep, that's the coverage we Star readers crave. Not.